HOWL

NASDAQ · Biotechnology

Werewolf Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.61

+0.01 (+1.02%)

As of Feb 8, 2:22 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 75%

Hold 3 25%

Sell 0 0%

Price Target

Analyst Price Target +6,486.1% upside

Low Target $26.90

Average Target $40.32

High Target $53.74

Current Price $0.61

Current
$0.61

Target
$40.32

$26.90 $40.32 avg $53.74

Scenario Analysis

Bear Case

$26.90

4,294.0%

Low target

Base Case

$40.32

+6,486.1%

Avg target

Bull Case

$53.74

+8,678.2%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$36.44

-98.3% from high

52-Week Low

$21.58

+-97.2% from low

Target vs 52W High

$40.32

+10.6% vs high

Next Earnings Report

Mar 2, 2026 · After Market Close

14d

until earnings

EPS Est: $-0.36

Earnings in 14 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%